Literature DB >> 34795020

European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma.

Nicole Concin1,2, François Planchamp3, Nadeem R Abu-Rustum4, Beyhan Ataseven2,5, David Cibula6, Anna Fagotti7, Christina Fotopoulou8, Pawel Knapp9, Christian Marth10, Philippe Morice11, Denis Querleu7,12, Jalid Sehouli13, Artem Stepanyan14, Cagatay Taskiran15,16, Ignace Vergote17, Pauline Wimberger18,19,20,21,22, Ignacio Zapardiel23, Jan Persson24,25.   

Abstract

BACKGROUND: Quality of surgical care as a crucial component of a comprehensive multi-disciplinary management improves outcomes in patients with endometrial carcinoma, notably helping to avoid suboptimal surgical treatment. Quality indicators (QIs) enable healthcare professionals to measure their clinical management with regard to ideal standards of care.
OBJECTIVE: In order to complete its set of QIs for the surgical management of gynecological cancers, the European Society of Gynaecological Oncology (ESGO) initiated the development of QIs for the surgical treatment of endometrial carcinoma.
METHODS: QIs were based on scientific evidence and/or expert consensus. The development process included a systematic literature search for the identification of potential QIs and documentation of the scientific evidence, two consensus meetings of a group of international experts, an internal validation process, and external review by a large international panel of clinicians and patient representatives. QIs were defined using a structured format comprising metrics specifications, and targets. A scoring system was then developed to ensure applicability and feasibility of a future ESGO accreditation process based on these QIs for endometrial carcinoma surgery and support any institutional or governmental quality assurance programs.
RESULTS: Twenty-nine structural, process and outcome indicators were defined. QIs 1-5 are general indicators related to center case load, training, experience of the surgeon, structured multi-disciplinarity of the team and active participation in clinical research. QIs 6 and 7 are related to the adequate pre-operative investigations. QIs 8-22 are related to peri-operative standards of care. QI 23 is related to molecular markers for endometrial carcinoma diagnosis and as determinants for treatment decisions. QI 24 addresses the compliance of management of patients after primary surgical treatment with the standards of care. QIs 25-29 highlight the need for a systematic assessment of surgical morbidity and oncologic outcome as well as standardized and comprehensive documentation of surgical and pathological elements. Each QI was associated with a score. An assessment form including a scoring system was built as basis for ESGO accreditation of centers for endometrial cancer surgery. © IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  endometrial neoplasms; surgical oncology

Mesh:

Year:  2021        PMID: 34795020     DOI: 10.1136/ijgc-2021-003178

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  1 in total

1.  Survival Analysis in Endometrial Carcinomas by Type of Surgical Approach: A Matched-Pair Study.

Authors:  Pluvio J Coronado; Agnieszka Rychlik; Laura Baquedano; Virginia García-Pineda; Maria A Martínez-Maestre; Denis Querleu; Ignacio Zapardiel
Journal:  Cancers (Basel)       Date:  2022-02-21       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.